Adipokines: New emerging roles in fertility and reproduction

Obstetrical and Gynecological Survey

Volumn 66, Issue 1, 2011, Pages 47-63

  Tersigni, Chiara ^a   Di Nicuolo, Fiorella ^a   D'Ippolito, Silvia ^a   Veglia, Manuela ^a   Castellucci, Mario ^b   Di Simone, Nicoletta ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN; RESISTIN;

ANGIOGENESIS; ARTICLE; CELL INVASION; FEMALE FERTILITY; HUMAN; INSULIN RESISTANCE; NIDATION; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PREGNANCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REPRODUCTION; TROPHOBLAST;

ADIPOKINES; EMBRYO IMPLANTATION; FEMALE; FERTILITY; HUMANS; INFERTILITY; INSULIN RESISTANCE; OBESITY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; REPRODUCTION;

EID: 79955436144     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e318217b0a4     Document Type: Article

References (168)

1. Wang P, Mariman E, Renes J, et al. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol. 2008;216:3-13. (Pubitemid 351813090)
2. Koning AM, Kuchenbecker WK, Groen H, et al. Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care. Hum Reprod Update. 2010;16:246-254.
3. Metwally M, Ledger WL, Li TC. Reproductive endocrinology and clinical aspects of obesity in women. Ann N Y Acad Sci. 2008;1127:140-146. (Pubitemid 351563093)
4. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763-770. (Pubitemid 28485436)
5. Baratta M. Leptin: from a signal of adiposity to a hormonal mediator in peripheral tissues. Med Sci Monit. 2002;8:282-292.
6. Funahashi H, Yamada S, Kageyama H, et al. Co-existence of leptin- and orexin-receptors in feeding-regulating neurons in the hypothalamic arcuate nucleus-a triple labeling study. Peptides. 2003;24:687-694. (Pubitemid 36929998)
7. Trayhurn P, Hoggard N, Mercer JG, et al. Leptin: fundamental aspects. Int J Obes Relat Metab Disord. 1999;23:22-28. (Pubitemid 29101372)
8. Webber J. Energy balance in obesity. Proc Nutr Soc. 2003; 62:539-543. (Pubitemid 36841629)
9. Rosická M, Krsek M, Matoulek M, et al. Serum ghrelin levels in obese patients: the relationship to serum leptin levels and soluble leptin receptors levels. Physiol Res. 2003;52:61-66. (Pubitemid 36356261)
10. Nagatani S, Guthikonda P, Thompson RC, et al. Evidence for GnRH regulation by leptin: leptin administration prevents reduced pulsatile LH secretion during fasting. Neuroendocrinology. 1998;67:370-376. (Pubitemid 28279739)
11. Spicer LJ. Leptin: a possible metabolic signal affecting reproduction. Domest Anim Endocrinol. 2001;21:251-270. (Pubitemid 34204088)
12. Joo JK, Joo BS, Kim SC, et al. Role of leptin in improvement of oocyte quality by regulation of ovarian angiogenesis. Anim Reprod Sci. 2010;119:329-334.
13. Karamouti M, Kollia P, Kallitsaris A, et al. Modulating effect of leptin on basal and follicle stimulating hormone stimulated steroidogenesis in cultured human lutein granulosa cells. J Endocrinol Invest. 2009;32:415-419.
14. Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270:26746-26749.
15. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adiposespecific gene dysregulated in obesity. J Biol Chem. 1996; 271:10697-10703. (Pubitemid 26145805)
16. Maeda K, Okubo K, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose Most abundant Gene transcript 1). Biochem Biophys Res Commun. 1996;221:286-289. (Pubitemid 26136463)
17. Nakano Y, Tobe T, Choi-Miura NH, et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem. 1996;120:803-812. (Pubitemid 26385421)
18. Halleux CM, Takahashi M, Delporte ML, et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun. 2001;288:1102-1107. (Pubitemid 33131713)
19. Kadowaki T, Yamauchi T, Kubota N, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116:1784-1792. (Pubitemid 44033298)
20. Yamauchi T, Hara K, Kubota N, et al. Dual roles of adiponectin/ Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine. Curr Drug Targets Immune Endocr Metabol Disord. 2003;3:243-254.
21. Hug C, Wang J, Ahmad NS, et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/ adiponectin. Proc Natl Acad Sci USA. 2004;101:10308-10313. (Pubitemid 38924921)
22. Ledoux S, Campos DB, Lopes FL, et al. Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology. 2006;147:5178-5186. (Pubitemid 44790572)
23. Banerjee RR, Lazar MA. Dimerization of resistin and resistinlike molecules is determined by a single cysteine. J Biol Chem. 2001;28:25970-25973.
24. Filková M, Haluzík M, Gay S, et al. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol. 2009;133:157-170.
25. Nagaev I, Bokarewa M, Tarkowski A, et al. Human resistin is as systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS One. 2006;1: e31.
26. Patel SD, Rajala MW, Rossetti L, et al. Disulfide-dependent multimeric assembly of resistin family hormones. Science. 2004;304:1154-1158. (Pubitemid 38661851)
27. Gerber M, Boettner A, Seidel B, et al. Serum resistin levels of obese and lean children and adoscents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab. 2005;90: 4503-4509. (Pubitemid 41159333)
28. Chen J, Wang L, Boeg YS, et al. Differential dimerization and association among resistin family proteins with implications for functional specificity. J Endocrinol. 2002;175:499-504. (Pubitemid 35414395)
29. McTernan PG, Kusminski CM, Kumar S. Resistin. Curr Opin Lipidol. 2006;17:170-175.
30. Ghosh S, Singh AK, Aruna B, et al. The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications. Gene. 2003;305: 27-34. (Pubitemid 36197863)
31. Bain JN, Cheema PS, Bahouth SW, et al. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun. 2003;300:674-678. (Pubitemid 36268889)
32. Savage DB, Sewter CP, Klenk ES, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferatorsactivated receptor-gamma action in humans. Diabetes. 2001;50:2199-2202. (Pubitemid 33641901)
33. Nagaev I, Smith U. Insuline resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun. 2001;285: 561-564. (Pubitemid 32918109)
34. Arner P. Resistin: yet another adipokine tells us that men are not mice. Diabetologia. 2005;48:2203-2205. (Pubitemid 41618907)
35. Seow KM, Juan CC, Hsu YP, et al. Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles. Hum Reprod. 2005;20:117-121.
36. Chen YC, Tsai EM, Chen HS, et al. Serum resistin level is a predictor of ovarian response in in vitro fertilisation cycle. Acta Obstet Gynecol Scand. 2007;86:963-967.
37. Panidis D, Koliakos G, Kourtis A, et al. Serum resistin levels in women with polycystic ovary syndrome. Fertil Steril. 2002; 81:361-366.
38. Raposinho PD, Pierroz DD, Broqua P, et al. Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism. Mol Cell Endocrinol. 2001;185:195-204. (Pubitemid 33103968)
39. Al-Daghri N, Bartlett WA, Jones AF, et al. Role of leptin in glucose metabolism in type 2 diabetes. Diabetes Obes Metab. 2002;4:147-155. (Pubitemid 34567671)
40. Heymsfield SB, Greenberg AS, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA. 1999;282:1568-1575. (Pubitemid 29504050)
41. Frü hbeck G, Salvador J. Relation between leptin and the regulation of glucose metabolism. Diabetologia. 2000;43:3-12.
42. Wallace AM. Measurement of leptin and leptin binding in the human circulation. Ann Clin Biochem. 2000;37:244-252. (Pubitemid 30242754)
43. Brichard SM, Delporte ML, Lambert M. Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res. 2003;35:337-342. (Pubitemid 37102677)
44. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007;380:24-30. (Pubitemid 46498041)
45. Spranger J, Mohlig M, Wegewitz U, et al. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol. 2004;61: 738-746. (Pubitemid 40006795)
46. Kharroubi I, Rasschaert J, Eizirik DL, et al. Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun. 2003;312:1118-1122. (Pubitemid 37490931)
47. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316:129-139.
48. Saltiel AR. You are what you secrete. Nat Med. 2001;7:887-888. (Pubitemid 32756414)
49. Shuldiner AR, Yang R, Gong DW. Resistin, obesity and insulin resistance-the emerging role of the adipocyte as an endocrine organ. N Engl J Med. 2001;345:1345-1346.
50. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307-312. (Pubitemid 32151228)
51. Kim KH, Lee K, Moon YS, et al. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001;276:11252-11256. (Pubitemid 38089312)
52. Rajala MW, Lin Y, Ranalletta M, et al. Cell type-specific expression and coregulation of murine resistin and resistinlike molecole-alpha in adipose tissue. Mol Endocrinol. 2002; 16:1920-1930. (Pubitemid 34828098)
53. Steppan CM, Lazer MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002;13:18-23. (Pubitemid 36734011)
54. Makimura H, Mizuno TM, Bergen H, et al. Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. Am J Physiol Endocrinol Metab. 2002;283:E1266-E1271. (Pubitemid 35340634)
55. Adeghate E. An update on the biology and physiology of resistin. Cell Mol Life Sci. 2004;61:2485-2496. (Pubitemid 39586513)
56. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med. 2004;255:439-447. (Pubitemid 38446357)
57. Azuma K, Katsukawa F, Oguchi S, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res. 2003;1:1997-1001.
58. Silha JV, Krsek M, Skrha JV, et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003;149:331-335. (Pubitemid 37304704)
59. Utzschneider KM, Carr DB, Tong J, et al. Resistin is not associated with insulin sensitivity or the metabolicsyndrome in humans. Diabetologia. 2005;48:2330-2333. (Pubitemid 41618925)
60. Dick GM, Katz PS, Farias M III, et al. Resistin impairs endothelium-dependent dilation to bradykinin, but not acetylcholine, in the coronary circulation. Am J Physiol Heart Circ Physiol. 2006;291:H2997-H3002. (Pubitemid 44904101)
61. Ort T, Arjona AA, Macdougall JR, et al. Recombinant human FIZZ3/resistin stimulates lipolysis in cultured human adipocytes, mouse adipose explants and in normal mice. Endocrinology. 2005;146:2200-2209. (Pubitemid 40577507)
62. Patel L, Buckels AC, Kinghorn IJ, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003; 300:472-476. (Pubitemid 38375833)
63. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382: 250-252. (Pubitemid 26251358)
64. Amstalden M, Garcia MR, Williams SW, et al. Leptin gene expression, circulating leptin, and luteinizing hormone pulsatility are acutely responsive to short-term fasting in prepubertal heifers: relationships to circulating insulin and insulin-like growth factor I. Biol Reprod. 2000;63:127-133. (Pubitemid 30429394)
65. Henry BA, Goding JW, Tilbrook AJ, et al. Intracerebroventricular infusion of leptin elevates the secretion of luteinising hormone without affecting food intake in long-term foodrestricted sheep, but increases growth hormone irrespective of bodyweight. J Endocrinol. 2001;168:67-77. (Pubitemid 32099354)
66. Whisnant CS, Harrell RJ. Effect of short-term feed restriction and refeeding on serum concentrations of leptin, luteinizing hormone and insulin in ovariectomized gilts. Domest Anim Endocrinol. 2002;22:73-80. (Pubitemid 34552926)
67. Moschos S, Chan JL, Mantzoros CS. Leptin and reproduction: a review. Fertil Steril. 2002;77:433-444. (Pubitemid 34182809)
68. Thong FS, Graham TE. Leptin and reproduction: is it a critical link between adipose tissue, nutrition, and reproduction? Can J Appl Physiol. 1999;24:317-336.
69. Yu WH, Walczewska A, Karanth S, et al. Nitric oxide mediates leptin-induced luteinizing hormone-releasing hormone (LHRH) and LHRH and leptin-induced LH release from the pituitary gland. Endocrinology. 1997;138:5055-5058. (Pubitemid 27460948)
70. De Biasi SN, Apfelbaum LI, Apfelbaum ME. In vitro effect of leptin on LH release by anterior pituitary glands from female rats at the time of spontaneous and steroid-induced LH surge. Eur J Endocrinol. 2001;145:659-665. (Pubitemid 33061913)
71. Amstalden M, Spencer TE, Harms PG, et al. Expression of leptin receptor and suppressor of cytokine signaling-3 genes in adenohypophysis of normal-fed and fasted cows. Reprod Biol. 2005;52:237-245.
72. Chehab FF, Qiu J, Mounzih K, et al. Leptin and reproduction. Nutr Rev. 2002;60:S39-S46.
73. Riad-Gabriel MG, Jinagouda SD, Sharma A, et al. Changes in plasma leptin during the menstrual cycle. Eur J Endocrinol. 1998;139:528-531. (Pubitemid 28539708)
74. Brannian JD, Hansen KA. Leptin and ovarian folliculogenesis: implications for ovulation induction and ART outcomes. Semin Reprod Med. 2002;20:103-112. (Pubitemid 34764274)
75. Karlsson C, Lindell K, Svensson E, et al. Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab. 1997;82:4144-4148. (Pubitemid 27525529)
76. Lindheim SR, Sauer MV, Carmina E, et al. Circulating leptin levels during ovulation induction: relation to adiposity and ovarian morphology. Fertil Steril. 2000;73:493-498. (Pubitemid 30109643)
77. Butzow TL, Moilanen JM, Lehtovirta M, et al. Serum and follicular fluid leptin during in vitro fertilization: relationship among leptin increase, body fat mass, and reduced ovarian response. J Clin Endocrinol Metab. 1999;84:3135-3139. (Pubitemid 30648891)
78. Combs TP, Pajvani UB, Berg AH, et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology. 2004;145:367-383. (Pubitemid 38094532)
79. Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002;277:25863-25866. (Pubitemid 34967064)
80. Ma X, Warram JH, Trischitta V, et al. Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab. 2002;87:4407-4410.
81. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8:731-737. (Pubitemid 34778727)
82. Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol. 1999;277:E1-E10. (Pubitemid 29356721)
83. Lanfranco F, Zitzmann M, Simoni M, et al. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin Endocrinol (Oxf). 2004;60:500-507. (Pubitemid 38482514)
84. Page ST, Herbst KL, Amory JK, et al. Testosterone administration suppresses adiponectin levels in men. J Androl. 2005;26:85-92. (Pubitemid 39665280)
85. Nishizawa H, Shimomura I, Kishida K, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocytederived protein. Diabetes. 2002;51:2734-2741. (Pubitemid 34970926)
86. Morash BA, Willkinson D, Ur E, et al. Resistin expression and regulation in mouse pituitary. FEBS Lett. 2002;526:26-30. (Pubitemid 35245686)
87. Nogueiras R, Barreiro ML, Caminos JE, et al. Novel expression of resistin in rat testis: functional role and regulation by nutritional status and hormonal factors. J Cell Sci. 2004;117: 3247-3257. (Pubitemid 39139910)
88. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-47.
89. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774-800. (Pubitemid 28009567)
90. Seow KM, Juan CC, Ho LT, et al. Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome. Human Reprod. 2007;22:1100-1106.
91. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980;50:113-116. (Pubitemid 10203585)
92. Dunaif A. Polycystic ovary syndrome and obesity. In: Bjorntorp P, Brodoff BN, eds. Obesity. Philadelphia, PA: Lippincott Co, 1992:594-605.
93. Marsden PJ, Murdoch A, Taylor R. Severe impairment of insulin action in adipocytes from amenorrheic subjects with polycystic ovary syndrome. Metabolism. 1994;43:1536-1542. (Pubitemid 24382705)
94. Rosenbaum D, Haber RS, Dunaif A. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol. 1993;264:E197-E202. (Pubitemid 23077359)
95. Brzechffa PR, Jakimiuk AJ, Agarwal SK, et al. Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81:4166-4169. (Pubitemid 26380435)
96. Mantzoros CS, Dunaif A, Flier JS. Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82:1687-1691. (Pubitemid 127495169)
97. Laughlin GA, Morales AJ, Yen SS. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. J Clin Endocrinol Metab. 1997; 82:1692-1696. (Pubitemid 127495170)
98. Rouru J, Anttila L, Koskinen P, et al. Serum leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82:1697-1700. (Pubitemid 127495171)
99. Moran LJ, Meyer C, Hutchison SK, et al. Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention. J Endocrinol Invest. 2010;33:258-265.
100. Pehlivanov B, Mitkov M. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Eur J Contracept Reprod Health Care. 2009;14:153-159.
101. Ardawi MS, Rouzi AA. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril. 2005;83:1708-1716. (Pubitemid 40824803)
102. Carmina E, Bucchieri S, Mansueto P, et al. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril. 2009;91:1332-1335.
103. Carmina E, Orio F, Palomba S, et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med. 2006;119:356.e1-e6.
104. Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, et al. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod. 2006;21:2257-2265. (Pubitemid 44530598)
105. Aroda V, Ciaraldi T, Chang S, et al. Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin ratio. Fertil Steril. 2008;89: 1200-1208. (Pubitemid 351671715)
106. Karkanaki A, Piouka A, Katsikis I, et al. Fertil Steril. 2009;92: 2078-2081.
107. Orio F, Palomba S, Cascella T, et al. Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2004; 89:110-115.
108. Yilmaz M, Bukan N, Demirci H. Serum resistin and adiponectin levels in women with polycystic ovary syndrome. Gynecol Endocrinol. 2009;25:246-252.
109. Seow KM, Tsai YL, Juan CC, et al. Omental fat expression of adiponectin and adiponectin receptors in non-obese women with PCOS: a preliminary study. Reprod Biomed Online. 2009;19:577-582.
110. Senay A, Mithat B, Alpaslan T, et al. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome. Gynecol Endocrinol. 2009;15:1-6.
111. Panidis D, Kourtis A, Farmakiotis D, et al. Serum adiponectin levels in women with polycystic ovary syndrome. Hum Reprod. 2003;18:1790-1796. (Pubitemid 37107549)
112. Carmina E, Orio F, Palomba S, et al. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol. 2005;152:389-394. (Pubitemid 40439491)
113. Munir I, Yen HW, Baruth T, et al. Resistin stimulation of 17-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:4852-4857. (Pubitemid 41159382)
114. Shimonovitz S, Hurwitz A, Dushnik M, et al. Developmental regulation of the expression of 72 and 92 kDa type collagenases in human trophoblasts: a possible mechanism for control of trophoblast invasion. Am J Obstet Gynecol. 1994; 171:832-838. (Pubitemid 24312373)
115. Staun-Ram E, Goldman S, Gabarin D, et al. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol. 2004;2:59.
116. Wang H, Wen Y, Mooney S, et al. Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human preimplantation embryos. Fertil Steril. 2003;80:736-742. (Pubitemid 37152387)
117. Smith SK. Angiogenesis and implantation. Hum Reprod. 2000;15:59-66. (Pubitemid 32058475)
118. Torry DS, Leavenworth J, Chang M, et al. Angiogenesis in implantation. J Assist Reprod Genet. 2007;24:303-315. (Pubitemid 47593603)
119. Nguyen M, Arkell J, Jackson CJ. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol. 2001;33: 960-970. (Pubitemid 32706688)
120. Nagase H, Woessner Jr JF. Matrix metalloproteinases. J Biol Chem. 1999;274:21491-21494.
121. Abecassis I, Olofsson B, Schmid M, et al. A induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. Exp Cell Res. 2003;291:363-376. (Pubitemid 37485724)
122. Castellucci M, De Matteis R, Meisser A, et al. Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol Hum Reprod. 2000;6:951-958.
123. Yura S, Sagawa N, Itoh H, et al. Resistin is expressed in the human placenta. J Clin Endocrinol Metab. 2003;88:1394-1397. (Pubitemid 36337806)
124. Di Simone N, Di Nicuolo F, Sanguinetti M, et al. Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes. J Endocrinol. 2006;189:691-699.
125. Benaitreau D, Dieudonné MN, Dos Santos E, et al. Antiproliferative effects of adiponectin on human trophoblastic cell lines JEG-3 and BeWo. Biol Reprod. 2009;80:1107-1114.
126. Jarvenpaa J, Vuoristo JT, Santaniemi M, et al. Adiponectin induced placental cell apoptosis could be mediated via the ADIPOR1-receptor in pre-eclampsia with IUGR. J Perinat Med. 2009;37:257-262.
127. Mu H, Ohashi R, Yan S, et al. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res. 2006;70:146-157.
128. Buchanan TA, Metzger BE, Freinkel N, et al. Insulin sensitiv- ity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol. 1990;162:1008-1014. (Pubitemid 20155423)
129. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000;71:1256S-1261S. (Pubitemid 30230526)
130. Catalano PM, Nizielski SE, Shao J, et al. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab. 2002;282:E522-E533. (Pubitemid 34654766)
131. Paradisi G, Biaggi A, Ferrazzani S, et al. Abnormal carbohydrate metabolism during pregnancy: association with endothelial dysfunction. Diabetes Care. 2002;25:560-564. (Pubitemid 41103353)
132. Butte NF, Wong WW, Treuth MS, et al. Energy requirements during pregnancy based on total energy expenditure and energy deposition. Am J Clin Nutr. 2004;79:1078-1087. (Pubitemid 41095961)
133. Kinoshita T, Itoh M. Longitudinal variance of fat mass deposition during pregnancy evaluated by ultrasonography: the ratio of visceral fat to subcutaneous fat in the abdomen. Gynecol Obstet Invest. 2006;61:115-118. (Pubitemid 43289485)
134. Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 1988;67: 341-347.
135. Barbour LA, Shao J, Qiao L, et al. Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynecol. 2002;186:512-517. (Pubitemid 34234166)
136. Kalkhoff RK, Jacobson M, Lemper D. Progesterone, pregnancy and the augmented plasma insulin response. J Clin Endocrinol Metab. 1970;31:24-28.
137. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001;60:349-356. (Pubitemid 32772450)
138. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003;144:2195-2200. (Pubitemid 36629866)
139. Farnier S, Krief M, Blache M, et al. Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathway. Int J Obes Relat Metab Disord. 2003;27:1178-1186. (Pubitemid 37281665)
140. Tamori Y, Sakaue H, Kasuga M. RBP4, an unexpected adipokine. Nat Med. 2006;12:30-31. (Pubitemid 43050050)
141. Masuzaki H, Ogawa Y, Sagawa N, et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med. 1997;3:1029-1033. (Pubitemid 27391961)
142. Henson MC, Castracane VD. Leptin in pregnancy: an update. Biol Reprod. 2006;74:218-229. (Pubitemid 43122272)
143. Islami D, Bischof P, Chardonnens D. Possible interactions between leptin, gonadotrophin-releasing hormone (GnRH-I and II) and human chorionic gonadotrophin (hCG). Eur J Obstet Gynecol Reprod Biol. 2003;110:169-175. (Pubitemid 37101314)
144. Lappas M, Permezel M, Rice GE. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology. 2005;146:3334-3342. (Pubitemid 41058105)
145. Mounzih K, Qiu J, Ewart-Toland A, et al. Leptin is not necessary for gestation and parturition but regulates maternal nutrition via a leptin resistance state. Endocrinology. 1998; 139:5259-5262. (Pubitemid 28533476)
146. Qiu C, Williams MA, Vadachkoria S, et al. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol. 2004;103:519-525. (Pubitemid 40459068)
147. Wang CN, Chang SD, Peng HH, et al. Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction. J Clin Endocrinol Metab. 2010;95:1431-1441.
148. Pighetti M, Tommaselli GA, D'Elia A, et al. Maternal serum and umbilical cord blood leptin concentrations with fetal growth restriction. Obstet Gynecol. 2003;102:535-543. (Pubitemid 37311217)
149. Nakatsukasa H, Masuyama H, Takamoto N, et al. Circulating leptin and angiogenic factors in preeclampsia patients. Endocr J. 2008;55:565-573. (Pubitemid 351949754)
150. Masuyama H, Segawa T, Sumida Y, et al. Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia. BJOG. 2010;117:314-320.
151. Altinova AE, Toruner F, Bozkurt N, et al. Circulating concentrations of adiponectin and tumor necrosis factor-alpha in gestational diabetes mellitus. Gynecol Endocrinol. 2007;23: 161-165. (Pubitemid 46570213)
152. D'Anna R, Baviera G, Corrado F, et al. Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders. Obstet Gynecol. 2005;106:340-344. (Pubitemid 41023273)
153. Chen D, Dong M, Fang Q, et al. Alterations of serum resistin in normal pregnancy and pre-eclampsia. Clin Sci. 2005;108: 81-84. (Pubitemid 40052288)
154. Sagawa N, Yura S, Itoh H, et al. Role of leptin in pregnancy: a review. Placenta. 2002;23:S80-S86.
155. Chiasson JL, el Achkar GG, Ducros F, et al. Glucose turnover and gluconeogenesis during pregnancy in women with and without insulin-dependent diabetes mellitus. Clin Invest Med. 1997;20:140-151. (Pubitemid 27267897)
156. Di Simone N, Di Nicuolo F, Marzioni D, et al. Resistin modulates glucose uptake and glucose transporter-1 (GLUT-1) expression in trophoblast cells. J Cell Mol Med. 2009;13: 388-397.
157. Bell GI, Kayano T, Buse JB, et al. Molecular biology of mammalian glucose transporters. Diabetes Care. 1990;13: 198-208. (Pubitemid 20092107)
158. Jansson T, Cowley EA, Illsley NP. Cellular localization of glucose transporter messenger RNA in human placenta. Reprod Fertil Dev. 1995;7:1425-1430. (Pubitemid 26133255)
159. Osawa H, Onuma H, Murakami A, et al. Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. Diabetes. 2002;51:860-862.
160. Stejskal D, Prosková J, Adamovská S, et al. Preliminary experience with resistin assessment in common population. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2002;146:47-49.
161. Fehmann HC, Heyn J. Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls. Horm Metab Res 2002;34:671-673. (Pubitemid 36398705)
162. Lappas M, Yee K, Permezel M, et al. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol. 2005;186:457-465. (Pubitemid 41404064)
163. Catalano PM, Huston L, Amini SB, et al. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol. 1999;180:903-916. (Pubitemid 29200557)
164. Megia A, Vendrell J, Gutierrez C, et al. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol. 2008;158:173-178. (Pubitemid 351298533)
165. Chen D, Fang Q, Chai Y, et al. Serum resistin in gestational diabetes mellitus and early postpartum. Clin Endocrinol 2007;67:208-211. (Pubitemid 47076293)
166. Cortelazzi D, Corbetta S, Ronzoni S, et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf). 2007;66: 447-453. (Pubitemid 46239308)
167. Barnes KM, Miner JL. Role of resistin in insulin sensitivity in rodents and humans. Curr Protein Pept Sci. 2009;10:96-107.
168. Mastrogiannis DS, Spiliopoulos M, Mulla W, et al. Insulin resistance: the possible link between gestational diabetes mellitus and hypertensive disorders of pregnancy. Curr Diab Rep. 2009;9:296-302.